| Low risk | High risk | Male | Female | All population | |||||
---|---|---|---|---|---|---|---|---|---|---|
Estimate | 95% CI | Estimate | 95% CI | Estimate | 95% CI | Estimate | 95% CI | Estimate | 95% CI | |
Outcome: BMI | ||||||||||
 Intercept (BMI) | 21.27 | (20.98, 21.55) | 22.16 | (21.81, 22.50) | 21.78 | (21.42, 22.13) | 21.63 | (21.35, 21.92) | 21.65 | (21.42, 21.87) |
 Slope (BMI) | 1.11 | (1.03, 1.18) | 1.12 | (1.03, 1.22) | 1.39 | (1.32, 1.48) | 0.9 | (0.82, 0.98) | 1.12 | (1.06, 1.18) |
 Cov(BMI) | −0.30 | (−0.72, 0.11) | −0.17 | (−0.76, 0.40) | −0.46 | (−1.07, 0.13) | −0.19 | (−0.58, 0.19) | −0.23 | (−0.59, 0.12) |
Outcome: PA | ||||||||||
 Intercept (PA) | −0.04 | (−0.11, − 0.00) | 0.01 | (− 0.08, 0.09) | 0.21 | (0.12, 0.29) | −0.24 | (− 0.3, − 0.19) | 0.72 | (0.23, 1.22) |
 Slope (PA) | 0.001 | (−0.03, 0.02) | −0.02 | (− 0.05, 0.01) | −0.01 | (− 0.04, 0.02) | −0.004 | (− 0.03, 0.02) | −0.05 | (− 0.26, 0.15) |
 Cov (PA) | −0.05 | (− 0.10, 0.03) | −0.01 | (− 0.07, 0.05) | −0.04 | (− 0.11, 0.03) | −0.03 | (− 0.06, 0.01) | −0.03 | (− 0.08, 0.01) |
Parallel | ||||||||||
Cross-sectional associationc | ||||||||||
  Intercept (PA) → intercept (BMI) | 0.00 | (−0.02, 0.02) | 0.01 | (−0.01, 0.03) | −0.01 | (− 0.03, 0.007) | 0.02 | (− 0.01, 0.0.03) | 0.00 | (− 0.01, 0.02) |
Prospective associationd | ||||||||||
  Intercept (PA) →slope (BMI) | 0.27 | (0.14, 0.41) | 0.08 | (−0.07, 0.24) | 0.09 | (−0.07, 0.25) | 0.08 | (−0.03, 0.18) | 0.18 | (0.08, 0.28) |
Parallel associatione | ||||||||||
  Slope (PA)→ slope (BMI) | −0.07 | (−0.13, − 0.01) | −0.03 | (− 0.08, 0.02) | −0.06 | (− 0.11, − 0.01) | −0.04 | (− 0.09, 0.005) | −0.05 | (− 0.09, − 0.01) |